Work
1996-2006 – Unilever, Varying roles across Sales and Marketing
2006-2010 – General Manager Rosslyn Park F.C. (Rugby Union)
2010-2015 – Unilever, Asda followed by Out of Home Ice Cream Channel and Strategy Controller (Walls and Ben & Jerry’s)
2015 to Present – Managing Director Cawston Press
Loves
Rugby, ice cream and apples!
Family
Happily married with 3 children
Hobbies
– Sport (any)
– Spending time with family and friends
– Long walks or cycle rides in the countryside
– Experimenting in the garden
Meredith Frank-Molnia is currently employed as Vice President of Clinical Affairs at Vericel Corporation. Previously, Meredith held the position of Senior Director Clinical Management, while working at Axiom Real-Time Metrics Inc., where she established and expanded their Clinical Management department. Meredith has been in Clinical Project Management/Operations for 26 years in numerous roles of increasing responsibilities. Meredith has worked managing device/biologic and drug studies.
Maria is a Senior Consultant at the Tufts Center for the Study of Drug Development at Tufts University School of Medicine, where she focuses on pharmaceutical regulatory policy, technology adoption and digital transformation in the biopharmaceutical sector, and operational efficiency across the drug development lifecycle—from idea to patient.
Her work has been published in leading health policy and medical journals, including JAMA Network Open, Nature Communications, Therapeutic Innovation & Regulatory Science, and Clinical Pharmacology & Therapeutics. She speaks regularly at domestic and international conferences and serves as a peer reviewer for several journals including npj Digital Medicine, Contemporary Clinical Trials, Scientific Reports, BMC Clinical Research Methodology, and Health Research Policy and Systems.
Previously, Maria held advisory and strategy roles at NewYork-Presbyterian (Weill Cornell Medicine and Columbia University College of Physicians and Surgeons), Cleveland Clinic Innovations, and served on the management team of Shield Biotech, an early-stage cancer immunotherapy company and Cleveland Clinic spinoff.
Maria holds a bachelor’s degree with honors in economics from Stony Brook University and a Master of Arts in Law and Diplomacy (MALD), with a concentration in international economics, from The Fletcher School of Law and Diplomacy at Tufts University.
Research Assistant Professor at Tufts University School of Medicine and Director of Sponsored Projects at Tufts CSDD.
Expertise in benchmarking drug development operating practices.
Research focus includes outsourcing and partnerships; clinical supplies; investigative site initiation and management; patient recruitment and retention; and the use of technologies and digital solutions in clinical trials.
Published extensively and is a frequent speaker at global conferences.
Current Initiatives Include:
• Study volunteer diversity in clinical trials
• Benchmarking patient recruitment and retention practices
• Industry use of automation, IT technologies and applications
Customer-focused healthcare manager with 20+ years of experience (11 years at Takeda/Shire, 7 years at Pfizer/Wyeth) in Clinical Research and Pharmaceutical industries. Expertise managing teams (up to 6 employees); overseeing complex vendor relationships; and negotiating clinical vendor and investigator contracts, and phase I–IV master service agreements. Proven record implementing innovative tools, processes, metrics, strategic practices, and global trainings to improve supplier and site management, outsourcing management, vendor qualification, vendor accountability, contract negotiations, compliance, and profitability. Earned numerous awards for exceeding goals and work excellence.
Dedicated to supporting rare disease patients and caregivers through creating innovative partnerships which allow patients to access resources easily. Demonstrated history of working in the Consumer Product Goods industry. Skilled in Brand Partnerships, Relationship Building, Account Management, Sales, Marketing, and Team Building. Master’s Degree focused in Business Administration and Integrated Communications from Suffolk University – Sawyer Business School.
George Tetz, MD, PhD, and CEO/Cofounder of Second Life Group, has dedicated his life’s work to addressing some of medicine’s most unmet needs.
Second Life Group includes three different clinical-stage entities, including Second Life Therapeutics, Second Life Diagnostics, and Second Life Vaccines. Together, these companies address some of the most critical, unmet needs in medicine, including advanced solid tumors, antibiotic resistance and longevity with first-in-class personalized medicines and medical devices.
Throughout his career as both a medical practitioner and researcher, Dr. Tetz has focused on applying cutting-edge multifactorial approaches to a variety of medical problems. One of his most groundbreaking findings is the existence of the previously unknown Universal Receptive System and Teazeled receptors. With this discovery, Dr. Tetz is modulating cellular memory for the first time, bringing cell control to a new and unprecedented level.
Dr. Tetz began his career as a medical practitioner, then earned his PhD in molecular microbiology. He serves as Director of the Department of Systems Biology at the Human Microbiology Institute, where he played an integral role in groundbreaking studies. Dr. Tetz is also a member of the American Society for Microbiology, Society for Neurosciences, and New York Academy of Sciences.
Rinaldo leads the Clinical Procurement team at Sarepta Therapeutics; which focuses on the clinical trial outsourcing for phases 1 through 3. His tenure as a Procurement professional includes roles at large and small organizations across both pharmaceuticals as well as biotech organizations. He has an MBA from Northeastern University and is a Certified Professional of Supply Management.
Stefan N. Lukianov, AM MS is the first-time JHU grad student founder of Salve Therapeutics, Inc. of Los Angeles, CA. He has undergraduate degrees from the University of Maine and masters from the University of Pittsburgh and Harvard University in the biomedical sciences. He has worked in reputable labs at Boston Children’s Hospital, Brigham and Women’s Hospital, McLean Hospital and the UPMC Hillman Cancer Center. He also has extensive experience in science journalism and education that contribute to his company leadership and vision.
John Seman is the CEO and Founder of REVITALE Pharma. He began his career working in Big Pharma – Johnson & Johnson and Bristol Myers Squibb – in sales, marketing and business development. The second half of his career was spent as a serial entrepreneur having Founded a half dozen companies that provided either products or services for the pharmaceutical industry. John earned his bachelor’s and master’s degrees from the Massachusetts College of Pharmacy.
